• ARCA EGFP mRNA for Transfection Controls

  2026-09-13

  Use ARCA EGFP mRNA as a rapid, direct fluorescence control for separating delivery failure from weak mammalian cell gene expression. Its capped, polyadenylated design also supports practical comparisons between lipid transfection, in situ electroporation, and emerging delivery workflows.

• ZK53: Human Mitochondrial ClpP Workflows

  2026-09-12

  ZK53 is a selective human mitochondrial serine protease ClpP activator for connecting mitochondrial proteostasis with cancer-cell stress responses. Its orthogonal biochemical assays, cell-based mitochondrial readouts, and reported lung and colorectal cancer applications support a practical workflow from target validation to translational modeling.

• AZ505: A Practical SMYD2 Inhibitor Workflow

  2026-09-11

  AZ505 combines substrate-competitive SMYD2 inhibition with strong biochemical selectivity, making it useful for separating SMYD2-dependent methylation from broader methyltransferase effects. This guide translates that profile into practical biochemical, cellular, fibrosis, and cancer biology workflows, with controls and troubleshooting steps designed for reproducible results.

• Prednisone Workflows for Immune Cell Assays

  2026-09-11

  Prednisone enables mechanism-driven models of lymphocyte suppression, G1 arrest, and apoptosis, with practical value in immunology and neurodegeneration research. This guide combines solvent control, PBL assay design, apoptosis readouts, and matrix-aware metabolomics concepts for more reproducible experiments.

• WAY-100635 in Serotonin Pain Assays

  2026-09-10

  WAY-100635 is a selective 5-HT1A antagonist for separating serotonergic receptor function from broader pain and affective phenotypes. This assay-focused guide connects receptor pharmacology with cannabidiol research, behavioral design, and translational imaging decisions.

• Zika Virus NS5 Targets a STAT2 Coiled-Coil Degron

  2026-09-10

  Parisien and colleagues identified the human STAT2 coiled-coil domain as both necessary and sufficient for Zika virus NS5 binding and proteasome-associated STAT2 destruction. Their mapping of the first two coiled-coil helices defines a focused interface for interferon antagonism and provides a mechanistic framework for studying viral immune evasion.

• Ceftazidime Workflows for Gram-Negative Research

  2026-09-09

  Ceftazidime supports practical susceptibility, time-kill, and resistance-transmission workflows centered on Gram-negative organisms, especially Pseudomonas aeruginosa. This guide connects assay design with plasmid-aware surveillance so researchers can distinguish antimicrobial phenotype from the genetic routes that sustain resistance.

• nor-NOHA Acetate for Arginase Assays

  2026-09-09

  nor-NOHA acetate provides a reversible way to test how arginine allocation influences tumor phenotypes, nitric oxide biology, and vascular readouts. Its strongest use is as a mechanistic comparator: pair arginase activity measurements with proliferation, apoptosis, invasion, or immune-cell assays rather than treating one endpoint as proof of pathway engagement.

• QX77 Molecular Chaperone Activator Guide

  2026-09-08

  QX77 is a molecular chaperone activator for chaperone-mediated autophagy research and stem cell biology research. Product information associates it with LAMP2A and Rab11 upregulation, ES cell self-renewal inhibition, and differentiation, while current BPD evidence provides related autophagy context rather than direct QX77 validation.

• Cyclo (-RGDfC): From Target Biology to Assay Design

  2026-09-08

  Cyclo (-RGDfC) is a cyclic RGD peptide for investigating integrin-mediated cell adhesion, tumor targeting, and angiogenesis. This article connects its αvβ3-binding biology with practical assay controls and lessons from canine osteosarcoma viability research.

• 2-NBDG: From Uptake Signal to Metabolic Insight

  2026-09-07

  2-NBDG enables fluorescent measurement of cellular glucose uptake, but its greatest value comes from connecting transport kinetics with metabolic mechanism. This guide explains how to interpret 2-NBDG data using the ERK/PKM2 arsenic-hepatocyte study as a model for rigorous glucose metabolism assays.

• Gemcitabine Assays for DNA Damage and Apoptosis

  2026-09-07

  Build reproducible Gemcitabine workflows that connect replication stress with checkpoint activation, apoptosis, and cancer-cell response. The guide combines dose-and-pulse design with gastric cancer stem-cell biology from the TAK1–YAP reference study, while clearly separating evidence from practical assay recommendations.

• Cyclic di-GMP and Biofilm Antibiotic Persistence

  2026-09-05

  The 2024 eLife study identifies cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during early biofilm development. By linking adhesion-stage signaling to DNA double-strand breaks, genome instability, and persister formation, the work refines current models of biofilm resilience and suggests more precise designs for persistence research.

• ASB3-Mediated MAVS Degradation in Antiviral Immunity

  2026-09-04

  The 2024 Cell Death & Differentiation study identifies ASB3 as an inducible E3 ligase that suppresses antiviral innate immunity by promoting K48-linked ubiquitination and proteasomal degradation of MAVS. Genetic, biochemical, virological, and animal experiments connect this mechanism to reduced TBK1–IRF3 signaling, impaired type I interferon production, and increased susceptibility to influenza infection.

• Phosbind Biotin for Protein Phosphorylation Analysis

  2026-09-04

  Phosbind Biotin enables sequence-independent Western Blot detection of phosphorylated proteins without relying on phospho-specific antibodies. Its biotin–streptavidin-HRP workflow is particularly useful for comparing phosphorylation changes in plant drought-response models and signal transduction pathway research.

7338 records 1/490 page Next 12345 下5页 Last page